ATE536886T1 - Stabilisierte feste zusammensetzungen von modifizierter faktor vii - Google Patents

Stabilisierte feste zusammensetzungen von modifizierter faktor vii

Info

Publication number
ATE536886T1
ATE536886T1 AT03720286T AT03720286T ATE536886T1 AT E536886 T1 ATE536886 T1 AT E536886T1 AT 03720286 T AT03720286 T AT 03720286T AT 03720286 T AT03720286 T AT 03720286T AT E536886 T1 ATE536886 T1 AT E536886T1
Authority
AT
Austria
Prior art keywords
factor vii
modified factor
solid compositions
stabilized solid
composition
Prior art date
Application number
AT03720286T
Other languages
English (en)
Inventor
Hanne Nedergaard
Lars Hansen
Niels Klausen
Troels Kornfelt
James Flink
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE536886T1 publication Critical patent/ATE536886T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03720286T 2002-05-03 2003-05-02 Stabilisierte feste zusammensetzungen von modifizierter faktor vii ATE536886T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200677 2002-05-03
PCT/DK2003/000287 WO2003092731A1 (en) 2002-05-03 2003-05-02 Stabilised solid compositions of modified factor vii

Publications (1)

Publication Number Publication Date
ATE536886T1 true ATE536886T1 (de) 2011-12-15

Family

ID=29286050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03720286T ATE536886T1 (de) 2002-05-03 2003-05-02 Stabilisierte feste zusammensetzungen von modifizierter faktor vii

Country Status (6)

Country Link
EP (1) EP1503798B8 (de)
JP (1) JP5184738B2 (de)
AT (1) ATE536886T1 (de)
AU (1) AU2003223925A1 (de)
ES (1) ES2377959T3 (de)
WO (1) WO2003092731A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
EP2060259B1 (de) 2001-11-01 2010-01-20 Spectrum Pharmaceuticals, Inc. Medizinische Zusammensetzungen zur intravesikalen Behandlung von Blasenkrebs
JP2005530683A (ja) 2001-12-21 2005-10-13 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第vii因子ポリペプチドの液体組成物
CN101912601B (zh) 2002-06-21 2012-08-29 诺和诺德医疗保健公司 因子vii多肽的稳定化固体组合物
EP3103869A1 (de) * 2003-03-18 2016-12-14 Novo Nordisk Health Care AG Verfahren zur herstellung von factor vii polypeptiden
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
ES2382157T3 (es) 2003-06-25 2012-06-05 Novo Nordisk Health Care Ag Composición líquida de polipépttidos del factor VII
EP2311437A1 (de) * 2003-12-19 2011-04-20 Novo Nordisk Health Care AG Stabilisierte Zusammensetzungen von Faktor-VII-Polypeptiden
AU2011203354B2 (en) * 2003-12-19 2014-07-17 Novo Nordisk Health Care Ag Stabilised compositions of factor VII polypeptides
PL1559431T3 (pl) * 2003-12-31 2007-10-31 Orthologic Corp Kompozycja farmaceutyczna dla pochodnych peptydu trombiny
WO2007010995A1 (ja) 2005-07-20 2007-01-25 Kyowa Medex Co., Ltd. 生体試料中のペプチドの安定化方法
JP5457036B2 (ja) * 2006-02-09 2014-04-02 スペクトラム ファーマシューティカルズ インコーポレイテッド 腫瘍酵素レベルの決定を含む膀胱癌の処置
US11077193B2 (en) 2015-04-21 2021-08-03 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Nerve growth factor composition and powder injection
CN110022855B (zh) 2016-10-07 2024-07-16 瑞泽恩制药公司 室温稳定的冻干蛋白质

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833982A (en) * 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
EP1479395A1 (de) * 1991-02-28 2004-11-24 Novo Nordisk A/S Modifizierter Faktor VII
US5788965A (en) * 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
US6310183B1 (en) * 1997-09-10 2001-10-30 Novo Nordisk A/S Coagulation factor VIIa composition
ATE264340T1 (de) * 1999-08-17 2004-04-15 Novo Nordisk Healthcare Ag Stabilisierung von gefriergetrocknetem kuchen
JP5090605B2 (ja) * 2000-05-03 2012-12-05 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 凝固因子viiの皮下投与

Also Published As

Publication number Publication date
EP1503798B1 (de) 2011-12-14
JP5184738B2 (ja) 2013-04-17
ES2377959T3 (es) 2012-04-03
AU2003223925A1 (en) 2003-11-17
EP1503798A1 (de) 2005-02-09
WO2003092731A1 (en) 2003-11-13
EP1503798B8 (de) 2012-03-14
JP2005530752A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
ATE334666T1 (de) Neue fettsäureanaloge zur behandlung der fettleber
DE60232017D1 (de) Flüssige zusammensetzung aus faktor vii polypeptiden
EP1503798B8 (de) Stabilisierte feste zusammensetzungen von modifizierter faktor vii
CO4970765A1 (es) Composiciones de bajo ph que contienen acido para el cuidado personal que exhiben picazon reducida
NO20034291D0 (no) 2-aminopropanolderivater
DK1303249T3 (da) Antimykotisk neglesammensætning
FI952610A7 (fi) Stabiloituja, nestemäisiä entsyymikoostumuksia
DE60217844D1 (de) Trocknungszusammensetzung
ATE172490T1 (de) Kalzium xylolsulfonat enthaltende, konzentrierte flüssige oder gelförmige geschirrspülmittelzusammensetzungen
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
ATE507822T1 (de) Stabilisierte zusammensetzungen von faktor-vii- polypeptiden
GB0101403D0 (en) Improvements in or relating to organic compositions
DE60115922D1 (de) Verfahren zur verzögerung der abbaugeschwindigkeit von bioabbaubarem polymer und bioabbaubare polymerzusammensetzungen
ATE226063T1 (de) Mineralwasser enthaltende zusammensetzungen
EE9900022A (et) Värvuskompositsioon, mis koosneb pürogalloolstruktuure sisaldavast agendist, raud(II)soolast ning orgaanilisest happest
DE60103940D1 (de) Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
DE69917245D1 (de) Betablocker enthaltende ophtalmische zusammensetzungen
TR200201392T2 (tr) Su ıslah maddesi
BRPI0411664A (pt) composição oral antiplaca aquosa estável
EE200200262A (et) Väetiselisand, mis sisaldab magneesium- ja kaltsiumsulfaati ja -karbonaati
MXPA03007757A (es) Composiciones que contienen creatina y creatinina.
ATE322165T1 (de) Verwendung von pflanzlichem material zur bekämpfung von landschnecken
DE60219462D1 (de) Verdickte wässrige zusammensetzungen
ATE205386T1 (de) Einphasige,transparente wässrige zusammensetzung
ATE165712T1 (de) Stabilisierte nahrungsmittelzusammensetzung